000 02857nam a22003735i 4500
001 309842
003 MX-SnUAN
005 20160429160326.0
007 cr nn 008mamaa
008 150903s2005 sz | o |||| 0|eng d
020 _a9783764373580
_99783764373580
024 7 _a10.1007/376437358-X
_2doi
035 _avtls000362709
039 9 _a201509030400
_bVLOAD
_c201404121551
_dVLOAD
_c201404091329
_dVLOAD
_y201402211056
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRM1-950
100 1 _aMechoulam, Raphael.
_eeditor.
_9350307
245 1 0 _aCannabinoids as Therapeutics /
_cedited by Raphael Mechoulam.
264 1 _aBasel :
_bBirkhäuser Basel,
_c2005.
300 _ax, 272 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aMilestones in Drug Therapy MDT
500 _aSpringer eBooks
505 0 _aCannabis in India: ancient lore and modern medicine -- Cannabinoid chemistry: an overview -- Cannabidiol as a potential medicine -- Endocannabinoids and regulation of fertility -- Cannabinoids in neurodegeneration and neuroprotection -- Role of the endocannabinoid system in learning and memory -- Cannabinoids and anxiety -- Cannabinoid targets for pain therapeutics -- Potential use of cannabimimetics in the treatment of cancer -- Cannabinoids: effects on vomiting and nausea in animal models -- The skeleton: stone bones and stoned heads? -- Cannabinoids and drugs of abuse -- Cannabinoids in appetite and obesity -- The development of Sativex® — a natural cannabis-based medicine.
520 _aIn recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783764370558
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/3-7643-7358-X
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c309842
_d309842